Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00727662 · ClinicalTrials.gov registry record · NA

A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue

A NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT00727662: Completed NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00727662 is a NA study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00727662, a NA study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

This randomized controlled trial will compare the effectiveness of an Iyengar Yoga intervention to a Wellness Seminar health education lecture series, for improvements in energy, mood and biological functioning in breast cancer survivors with persistent, post-treatment fatigue. It is anticipated that the Iyengar Yoga intervention will be feasible and acceptable to breast cancer survivors with minimal side effects and that the Yoga intervention will be effective in improving fatigue and physical performance.

Interventions

  • OTHER Iyengar Yoga
  • OTHER Wellness Seminar Series

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2008-06
Est. Completion 2010-12
Phase NA

What the finished NCT00727662 record still lists

NCT00727662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Iyengar Yoga is the first listed.

NCT00727662 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00727662 about?

NCT00727662 is a clinical study titled "A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue". This randomized controlled trial will compare the effectiveness of an Iyengar Yoga intervention to a Wellness Seminar health education lecture series, for improvements in energy, mood and biological functioning in breast cancer survivors with persistent, post-treatment fatigue. It is anticipated tha...

What is the current status of trial NCT00727662?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2008-06. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00727662?

The interventions under investigation include: Iyengar Yoga (OTHER), Wellness Seminar Series (OTHER).

Who is sponsoring clinical trial NCT00727662?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00727662's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00727662, the US trial registry maintained by the National Library of Medicine. NCT00727662 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.